Skip to main content
ConductScienceScienceDex

Markella V. Zanni

NIH Rank #7148
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9758176Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • OTHER HEALTH PROFESSIONS

NIH Funding · FY2024

Linked Award Amount
$1.7M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#7,148
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Markella V. Zanni. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Markella V. Zanni as a PI. Multi-PI records show the full award amount for context.

  • 1R01HL170905-01A1R01
    Effects of SGLT2 Inhibition on Coronary Flow Reserve and Other Key Indices Relevant to Type 2 Myocardial Infarction Risk among Women with HIV
    Massachusetts General Hospital
    $771.6K
    award amount
  • 5R01HL167645-02R01
    Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)
    University of Washington
    $743.2K
    award amount
  • 5K24AI157882-04K24
    Consequences of Persistent Immune Activation among ART-treated Women with HIV
    Massachusetts General Hospital
    $181.6K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Markella V. Zanni as a PI.

Massachusetts General Hospital
MA
$953.2K
2 grants
University of Washington
WA
$743.2K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7148
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Entered Top 25% Nationally
    Ranked #4485
  7. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Markella V. Zanni.

Chris Todd Longenecker
University of Washington
4
shared awards
Ntobeko Ayanda Bubele Ntusi
University of Washington
4
shared awards
Jordan E Lake
UT Health Science Center Houston
2
shared awards
Kristine Mace Erlandson
UT Health Science Center Houston
2
shared awards

Explore further

Find collaborators for Markella V. Zanni

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →
Markella V. Zanni | NIH Award Records | ConductScience